Hasil Pencarian  ::  Simpan CSV :: Kembali

"Perkembangan Bioteknologi, khususnya teknologi rekayasa genetika menyumbangkan berbagai manfaat bagi sektor pertanian dari pangan di dunia dalam dua dasawarsa terakhir ini. Rekayasa genetika dimanfaatkan untuk menciptakan keungugulan-keunggulan tertentu dari tanaman, maupun produk pangan, yang dinamakan Geneticaly Modified Organism (GMO) maupun produk-produk derivat dari GMO.Salah satu komoditas hasil rekayasa genetik yang sering diperbincangkan adalah tanaman transgenik. Tanaman transgenik memilki berbagai keunggulan dari tanaman-tanaman konvensional karena kemampuan menghasilkan pertahanan terhadap hama dan tanaman secara mandiri, maupun keunggulan-kunggulan lain seperti kandungan nutrisi yang lebib banyak, mudah beradaptasi terhadap Iingkungan,dsb. Namun demikian kemanfaatan bioteknologi maupun GMO juga mendapatkan kritik dari berbagai pengamat lingkungan hidup, maupun pemrhati pembangunan ditingkat internasional. Hal ini dikarenakan terdapat kekhawatiran bahwa dibalik keuntungan GMO juga terkaandung resiko maupun dampak negatif bagi kesehatan manusia dan lingkungan hidup, serta dampak ekonomi bagi negara berkembang.Dalam Konvensi Keanekaragaman Hayati, yang disepakati di Rio de Janeiro tahun 1992, para peserta Konferensi Bumi menyepakati perlunya negara membuat aturan-aturan mengenai penanganan bioteknologi. Khusus mengenai masalah prasedur keamanan hayati dari pergerakan lintas batas dari GMO diatur secara khusus dalam sebuah kesepakatan bernama: Cartagena Protocol on Biosafety to the Convention on Biological Diversity pada tahun 2000.Indonesia merupakan negara penandatangan Konvensi Keanekaragaman Hayati, yang juga telah memiliki peraturan mengenai keamanan hayati dan keamanan pangan produk rekayasa genetik di tingkat kementrian (peraturan menteri). Namun demikian ketika masyarakat menggugat keputusan dari Menteri Pertanian untuk melepas varietas kapas transgenik, ditemukan berbagai permasalahan hukum yang membuat permasalahan bioteknologi semakin meruncing. Peraturan tersebut tidak memadai untuk memberikan ruang bagi pembuat kebijakan maupun masyarakat dalam menilai kemanan hayati produk transgenik dan bioteknologi, maupun dampak bagi lingkungan hidup dan pembangunan di Indonesia. Kepentingan tersebut perlu dijembatnidengan peratifikasian Cartagena Protokol, dan adanya Undang-Undang Kemanan Hayati Bagi Produk Bioteknologi/Rekayasa Genetik."

"This book guides the reader through FDA regulation guidelines and outlines a comprehensive strategy for cost reduction in regulatory affairs and compliance. This book explains six strategies to cost-effectively comply with FDA regulations while maintaining product safety and improving public access through cost controls. It provides useful and practical guidance through industry case studies from pharmaceutical, biotech, and medical device industries."

"Focused manuscript on the potential use/role of miRNAs in bioprocessing, specifically the production of complex proteins in mammalian cells. With that in mind I propose a draft list of topics/chapters along the following lines, intro on CHO/bioprocessing/engineering challenges to set scene, genomic organization, biogenesis and mode of action, Identifying miRNA targets, computational prediction, transcriptomics, proteomices, UTR analysis, etc., miRNA expression in Chinese hamster ovary cells, miRNAs as engineering targets: pathway manipulation to impact bioprocess phenotypes, miRNAs as biomarkers, detection methods : northern, PCR, hybridization arrays, next gen seq, manipulation of expression in cultured cells : transient/stable disregulation, knockout."

"This book will focus on recent developments in isotope labeling methods for structural studies of small molecules, peptides, proteins and nucleic acids. The aim of the book is to serve as a compendium of isotope labeling for the biomolecular NMR community providing comprehensive coverage of the existing methods and latest developments along with protocols and practical hints on the various experimental aspects. The book will cover a wide range of topics in isotope labeling under one title including emerging areas of metabolonomics and solid state NMR."

"A unique, adaptable textbook for upper-level undergraduate and graduate courses emphasizing particular aspects of modern biotechnology.Features straightforward, jargon-free writing and extensive figures to help students make sense of complex biological systems and processes.Includes expanded coverage of the latest innovations in DNA sequencing techniques, therapeutics, vaccines, transgenic plants, and transgenic animals.Allows instructors to easily tailor the content to courses focusing on the fundamentals of biotechnology as well as courses dedicated to medical, agricultural, environmental, or industrial applications."

"This text book will bring together a mix of both internationally known and established senior scientists along side up and coming (but already accomplished) junior scientists that have varying expertise in fundamental and applied nanotechnology to biology and medicine."

"This book explores current research on nanomaterials in imaging and biological research, nanomaterials as a biosensing tool, DNA nanotechnology, nanomaterials for drug delivery, medicinal and therapeutic application and cytotoxicity of nanomaterials."

"This updated edition features concise background information on chromosome methods and applications, essential information on heteromorphism frequencies in normal and clinical populations as well as new listing and discussions of euchromatic, subtelomeric and FISH variants. The addition of two new sections make this an even more valuable reference than before. A section on common and rare fragile sites includes a short historical discussion, definitions and an extensive table of officially recognized sites that includes the HUGO name, chromosomal location, methods of induction, genes and references to the most recent molecular characterization. A new section on array CGH discusses the clinical challenge of interpreting copy number variations (CNVs) revealed by this newest technology, gives examples of various levels of interpretation and lists the several most common websites used in this interpretation."

"The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions) at present are heavily business-oriented, realize that in this particular industrial environment, that every dollar counts."

"This new volume in the series focuses on the particular IP issues of therapeutics, vaccines and molecular diagnostics. The first chapter concentrates on basics principles for protecting antibody compounds. Additional ways to create follow-up protection for antibody therapeutics are also discussed. The second chapter gives an overview of the patent landscape in molecular diagnostics, and discusses issues of patentability with respect to the different technologies and compounds used therein. The third chapter gives a broad overview of areas of law that are particularly relevant to the patenting of peptide vaccines and therapeutic peptides as products and in compositions. The scope of patentable subject matter is discussed, as it has been the focus of much wrangling and debate in the courts."